160 related articles for article (PubMed ID: 20075341)
1. Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan Alteplase Clinical Trial II (J-ACT II).
Mori E; Minematsu K; Nakagawara J; Yamaguchi T; Sasaki M; Hirano T;
Stroke; 2010 Mar; 41(3):461-5. PubMed ID: 20075341
[TBL] [Abstract][Full Text] [Related]
2. Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients: exploratory analysis of the Japan Alteplase Clinical Trial II.
Hirano T; Sasaki M; Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
Stroke; 2010 Dec; 41(12):2828-33. PubMed ID: 21030700
[TBL] [Abstract][Full Text] [Related]
3. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
[TBL] [Abstract][Full Text] [Related]
5. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.
Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M
Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714
[TBL] [Abstract][Full Text] [Related]
6. Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study.
Marks MP; Olivot JM; Kemp S; Lansberg MG; Bammer R; Wechsler LR; Albers GW; Thijs V;
Radiology; 2008 Nov; 249(2):614-23. PubMed ID: 18936316
[TBL] [Abstract][Full Text] [Related]
7. Stent-assisted endovascular thrombolysis versus intravenous thrombolysis in internal carotid artery dissection with tandem internal carotid and middle cerebral artery occlusion.
Lavallée PC; Mazighi M; Saint-Maurice JP; Meseguer E; Abboud H; Klein IF; Houdart E; Amarenco P
Stroke; 2007 Aug; 38(8):2270-4. PubMed ID: 17600235
[TBL] [Abstract][Full Text] [Related]
8. Posterior cerebral artery laterality on magnetic resonance angiography predicts long-term functional outcome in middle cerebral artery occlusion.
Ichijo M; Miki K; Ishibashi S; Tomita M; Kamata T; Fujigasaki H; Mizusawa H
Stroke; 2013 Feb; 44(2):512-5. PubMed ID: 23192760
[TBL] [Abstract][Full Text] [Related]
9. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
[TBL] [Abstract][Full Text] [Related]
10. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
[TBL] [Abstract][Full Text] [Related]
11. Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT Study.
Ohara T; Menon BK; Al-Ajlan FS; Horn M; Najm M; Al-Sultan A; Puig J; Dowlatshahi D; Calleja Sanz AI; Sohn SI; Ahn SH; Poppe AY; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Letteri F; Dey S; Evans JW; Goyal M; Hill MD; Almekhlafi M; Demchuk AM;
Stroke; 2021 Jan; 52(1):203-212. PubMed ID: 33317416
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of continuous transcranial duplex Doppler monitoring of middle cerebral artery occlusion in acute stroke patients: comparison of TCDD and thrombolysis in MCA recanalization.
Sanák D; Herzig R; Skoloudík D; Horák D; Zapletalová J; Köcher M; Kanovský P
J Neuroimaging; 2010 Jan; 20(1):58-63. PubMed ID: 19226343
[TBL] [Abstract][Full Text] [Related]
13. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
[TBL] [Abstract][Full Text] [Related]
14. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study.
Eggers J; König IR; Koch B; Händler G; Seidel G
Stroke; 2008 May; 39(5):1470-5. PubMed ID: 18340100
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of endovascular treatment for acute cerebral large-vessel occlusion: analysis of nationwide prospective registry.
Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Tanahashi N; Hyogo T; Yamagami H; Egashira Y;
J Stroke Cerebrovasc Dis; 2014; 23(5):1183-90. PubMed ID: 24424332
[TBL] [Abstract][Full Text] [Related]
16. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT).
Yamaguchi T; Mori E; Minematsu K; Nakagawara J; Hashi K; Saito I; Shinohara Y;
Stroke; 2006 Jul; 37(7):1810-5. PubMed ID: 16763187
[TBL] [Abstract][Full Text] [Related]
17. Intravenous alteplase versus rescue endovascular procedure in patients with proximal middle cerebral artery occlusion.
Strbian D; Mustanoja S; Pekkola J; Putaala J; Haapaniemi E; Paananen T; Kaste M; Lappalainen K; Tatlisumak T
Int J Stroke; 2015 Feb; 10(2):188-93. PubMed ID: 23013407
[TBL] [Abstract][Full Text] [Related]
18. DWI-ASPECTS as a predictor of dramatic recovery after intravenous recombinant tissue plasminogen activator administration in patients with middle cerebral artery occlusion.
Aoki J; Kimura K; Shibazaki K; Sakamoto Y
Stroke; 2013 Feb; 44(2):534-7. PubMed ID: 23212169
[TBL] [Abstract][Full Text] [Related]
19. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study.
Neumann-Haefelin T; du Mesnil de Rochemont R; Fiebach JB; Gass A; Nolte C; Kucinski T; Rother J; Siebler M; Singer OC; Szabo K; Villringer A; Schellinger PD;
Stroke; 2004 Jan; 35(1):109-14. PubMed ID: 14671246
[TBL] [Abstract][Full Text] [Related]
20. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
